Alfie

Overview

Alfie is a telemedicine company focused on democratizing access to precision weight loss medications [1]. Founded in 2022, the company is headquartered in New York City [2] and completed Y Combinator's Winter 2022 batch [3]. The company operates a virtual medical program based on research from Cleveland Clinic and Harvard that combines exercise, nutrition, and medications in a multimodal approach [5]. According to the company, its program demonstrates effectiveness 2x greater than standard prescription medication and 5x greater than habit change alone [5]. Alfie has a team of six [4] and has raised capital from investors including Goodwater Capital, Nina Capital, Air Force Ventures, and Phoenix Club, along with angel investors [5].

At Alfie, we've built a rigorous virtual medical program based on the top research from Cleveland Clinic and Harvard that allows us to precisely determine which weight loss regimen and (as needed) medications will be most effective for our members in a multimodal approach. We're optimizing exercise/nutrition/medications in complex care pathways like no one else has before. Our program has been shown to be 2x more effective than standard prescription medication and 5x more effective than habit change alone. We've raised capital from Goodwater Capital, Nina Capital, Air Force Ventures, and Phoenix Club, and various super angels including the founder of OpenTrons (medical labs automation; have raised $240 mill). Also, we're a Y Combinator graduate. [5]

Y Combinator's directory lists the company location as New York City, NY, USA; New York, NY, USA. [2]

Alfie Health lists its address as 222 Broadway, New York, New York, 10038. [6]

Growth & traction

Y Combinator lists a team size of 6. [4]